Results 211 to 220 of about 28,272 (264)

Evolocumab-induced allergic reaction in a post-partial gastrectomy patient: A case report. [PDF]

Medicine (Baltimore)
Hong X, Jiang X, Xu X, Xiong F, Huang X.
europepmc   +1 more source

Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy. [PDF]

Mol Biomed
Fan G, Zha J, Chen S, Cang P, Zhang Q, Yang J, Liu M.   +6 more
europepmc   +1 more source

Beyond LDL-C lowering: Distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency

, 2013
Minna T. Jänis, Kirill V. Tarasov, Hung Xuan Ta, Matti Suoniemi, Kim Ekroos, Reini Hurme, Terho Lehtimäki, Hannu Päivä, Marcus E. Kleber, Winfried März, Annik Prat, Nabil G. Seidah, Reijo Laaksonen   +12 more
openalex   +1 more source

2025 Egyptian guidelines for the management of dyslipidemia. [PDF]

Egypt Heart J
Reda A, Taha HS, Badran HM, Khamis H, Kamal S, Elserafy AS, Dawoud MH, Elamragy AA, Bendary A, Shaker MM.   +9 more
europepmc   +1 more source

PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]

Sci Rep
Akhtar W, Khan T, Neves E, Browne C, Tawil M, Lyster H, Dar O.   +6 more
europepmc   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipid Profile and Cardiovascular Events in High-Risk Diabetic Patients. [PDF]

Cureus
Patra V, Yella VR, Konda VGR, Sayana SB, Siripuram C, Konka S, Kandimalla R.   +6 more
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus [PDF]

Jun-Xu Gu, Kun Wang, Aimin Zhang, Yue Yin, Shanshan Li, Na Zhang, Li Qin, Chunyan Wang, Lin Pei, Mei Jia, Ming Su   +10 more
openalex   +1 more source

Remnant cholesterol in chronic obstructive pulmonary disease-phenotypes and pharmacotherapy matter. [PDF]

J Thorac Dis
Hao J, Gu X.
europepmc   +1 more source